Thursday morning snapshot

A snapshot of the early morning's equity news and key market movements.

Last night in the US: The Dow Jones closed down 61 points at 15,618, the NASDAQ finished down 21 points at 3930 and the S&P 500 ended the day down eight points at 1763.

This morning in London: The FTSE 100 is currently down 15 points at 6760.

FX and commodities: GBP/USD is down 21 pips at $1.6018,,EUR/USD is 39 pips weaker at $1.3696 and USD/JPY is 10 pips lower at ¥98.32. Brent crude is down 36 cents at $109.52 and gold  $6.15 lower at $1336,.

Latest news: Even though the US Federal Reserve kept its $85 billion monthly stimulus package in place, the accompanying comments were no more downbeat than in September, which considering the recent poor US economic data was perhaps slightly surprising.

Stocks: Astrazeneca continues to struggle, recording lower sales and profit. Croda International has seen a mild uptick in Q3 sales, and BT Group continues to see a steady stream of consumers subscribe to its sports package, with the total now standing at two million.

The day ahead: The Nationwide monthly house price index has once again risen by 1%. At 10am the latest EU unemployment rate is released, followed by US unemployment claims this afternoon.

All figures correct at 8.15am. All times London time.

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.